Fox Business - The Power to Prosper
Search Site

Schering-Plough

Related Topics

  1. Merck
  2. Bristol-Myers Squibb
  3. Pharmaceuticals
  4. Andrea Jung
  5. Avon Products
  6. Food And Drug Administration
Get updates on Schering-Plough
Avon Chairman Hassan Resigns from Board

Avon Products Inc. (AVP) said Chairman Fred Hassan, known in the industry as a savvy deal maker, has resigned from the board, just months after taking the chairman post.Mr. Hassan stepped down to "focus more time on his other professional commitments," the beauty-products company said.Mr. Hassan also serves as non-executive chairman of eye-care company Bausch & Lomb Holdings Inc.--which is currently planning to go public--and is a partner at private-equity firm Warburg Pincus."My other professional commitments have intensified, requiring more focus. So I have decided it is in the best interest of Avon for one of my board colleagues to take on the chairmanship," Mr. Hassan said in a statement.Current board member Doug Conant has been elected to the position of non-executive chairman, Avon said. He is the former CEO of Campbell Soup Co. (CPB).Mr. Hassan started as Avon's chairman at the beginning of the year, taking over for embattled former chief executive Andrea Jung. His move into the...

Read More ›

  1. Merck to Pay $688 Million to Settle 'Enhance' Trial Lawsuits

    Merck & Co. (MRK) will pay $688 million to settle two federal securities class-action lawsuits brought by investors who bought certain Merck and Schering-Plough Corp...

  2. Al's Emporium: Calling Dr. Schwag

    A few doctors didn't appreciate a comment I made in last week's column that pharmaceutical-industry reps unduly influence medical decisions by plying physicians with...

  3. FDA Denies Merck Request to Block Generic Form of Nasonex

    Merck & Co. (MRK) lost another round in its effort to block a competing generic copy of its Nasonex allergy nasal spray from entering the U.S. market.The U.S. Food a...

  4. India Revokes Patent on Merck Asthma Drug -Reuters

    Citing lack of invention, India has revoked a patent on an asthma drug made by Schering Corp., which was later bought by Merck & Co. (MRK), Reuters reported Tuesday....

  5. America's Most Valuable CEOs

    There is a nearly endless number of criteria that measure how well CEOs perform, whether they are paid fairly, and what metrics should be used for determining chief ...

  6. Merck to Move Global Headquarters to Summit NJ in Push to Cut Costs

    Merck & Co. (MRK) will move its global headquarters to an existing property in Summit, N.J., from Whitehouse Station, N.J. as the drug giant continues its cost-cutti...

  7. Avon Chairman Andrea Jung to Resign

    Avon Products Inc. (AVP) said Chairman Andrea Jung will step down at the end of the year and will be succeeded by Fred Hassan.Ms. Jung will continue as a senior advi...

  8. Merck's Anticlotting Drug Effective In Certain Patients

    The addition of Merck & Co.'s (MRK) experimental anticlotting drug vorapaxar to standard care reduced the risk of heart attacks and related events by 13% in a study ...

  9. Warburg Pincus Hires Francesco Granata To Identify Healthcare Deals

    Warburg Pincus said Monday it has appointed healthcare executive Francesco Granata to help the global buyout firm identify and evaluate deals in the biopharmaceutica...

  10. Merck Anti-Clotting Drug Meets Study Goal But Has Bleeding Risk

    An experimental anti-clotting drug from Merck & Co. (MRK) reduced the risk of heart attacks and related events in a clinical trial, but significantly increased bleed...

  11. How Big Business Influences The Super Committee Members

    “All politics is local”–Thomas Phillip “Tip” O’Neill, Jr., Speaker of the House, 1977 to 1987Twelve members of Congress have been tasked with producing legislation t...

  12. Merck gets subpoena tied to marketing of 3 drugs

    NEW YORK (Reuters) - The Department of Justice has issued Merck & Co <MRK.N> a subpoena seeking information about the drugmaker's marketing of three drugs acquired i...

  1. Some Drug Makers Cut Payments, Meals Provided to Doctors

    Two pharmaceutical companies that are among the biggest payers of fees to doctors reduced such spending last year by double-digit percentages, as greater transparenc...

  2. Top Court to Decide on Deals to Delay Cheaper Drugs

    The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper...

  3. Merck : FDA Extends Review of Sugammadex by 3 Months

    Merck & Co. (MRK) said the U.S. Food and Drug Administration has extended by three months its review of the company's application to market a new postsurgical drug.M...

  4. Long-serving Roche chairman to step down next year

    Roche's influential Chairman Franz Humer said on Tuesday he will not stand for re-election next year when he will have served 16 years at the helm of the Swiss drugm...

  5. Bausch & Lomb Names Robert Bertolini as New Financial Chief

    Contact lens maker Bausch & Lomb Inc. has named Robert Bertolini as its new chief financial officer effective immediately, replacing Brian J. Harris."Bob Bertolini's...

  6. Merck to Pay $688 Million to Settle Drug Study Suits

    Merck & Co. (MRK) agreed to pay $688 million to settle lawsuits claiming that shareholders lost money when the company reported negative results of a clinical trial ...

  7. Merck Pays $688M to Settle Investor Suit

    Merck (NYSE:MRK) agreed to pay $688 million on Thursday to settle two federal securities class-action lawsuits filed by Merck investors who claimed they lost money w...

‹ Prev123Next ›
Freebase CC-BY
Source: Schering-Plough on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL